Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

OSI Pharmaceuticals

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 2
Rounds per year 0.05
Lead investments 0
Exits 2
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Pharmaceutical
  • Medical
  • Biotechnology
  • Health Care
  • Therapeutics
Summary

In 1983 was created OSI Pharmaceuticals, which is appeared as Corporate Investor. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Farmingdale.

Among the various public portfolio startups of the fund, we may underline AVEO Pharmaceuticals, PhaseBio Pharmaceuticals For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Biotechnology, Medical. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

The standard case for the fund is to invest in rounds with 3 partakers. Despite the OSI Pharmaceuticals, startups are often financed by Venrock, Prospect Venture Partners, MPM Capital. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Johnson & Johnson Development Corporation, Hatteras Venture Partners. In the next rounds fund is usually obtained by New Enterprise Associates, Johnson & Johnson Development Corporation, Hatteras Venture Partners.

The top activity for fund was in 2009. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2018.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of OSI Pharmaceuticals:
Typical Co-investors
OSI Pharmaceuticals is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after OSI Pharmaceuticals:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Beijing Konruns Pharmaceutical Beijing, Changping, China
BioFund Management Finland, Helsinki, Southern Finland
China Super Media Holdings -
Fatima Ventures Lahore, Pakistan, Punjab
Flow Traders Amsterdam, Noord-Holland, The Netherlands
Hanhua Financial Holding Beijing, Beijing, China
Japan startup support Association Ikeda, Japan, Osaka Prefecture
K Street Capital District of Columbia, United States, Washington
Leerink Revelation Partners California, San Francisco, United States
Lu An Industrial China, Guangdong, Shenzhen
Media Investment GmbH -
NetWorth Partners California, San Diego, United States
Portico Ventures -
Sanko Holding Istanbul, Istanbul, Turkey
Sino-Century International Investment Beijing, China, Haidian
SummitVision Capital, LLC California, San Francisco, United States
Talis Capital England, London, United Kingdom
Tom Farms -
Zhongnan Jituan -
Zhongyi Ningbo Ecological Park China, Hebei, Zhongyi

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

PhaseBio Pharmaceuticals

Biotechnology
Medical
Medical Device
Pharmaceutical
$25M07 Jan 2010 Pennsylvania, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent OSI Pharmaceuticals?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 22M
Rounds per year 0.05
Peak activity year 2009
Lead investments 0
Exits 2
Group Appearance index 0.50

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

PhaseBio Pharmaceuticals

Biotechnology
Medical
Medical Device
Pharmaceutical
$25M07 Jan 2010 Pennsylvania, United States
Crunchbase icon

Content report

The following text will be sent to our editors: